Last reviewed · How we verify
miRNA quantification
At a glance
| Generic name | miRNA quantification |
|---|---|
| Sponsor | Dr.Waleed Samir |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients
- MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
- Pancreatic Cancer Detection Consortium
- Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
- An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer
- Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
- HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR
- Prostasomes as Diagnostic Tool for Prostate Cancer Detection
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- miRNA quantification CI brief — competitive landscape report
- miRNA quantification updates RSS · CI watch RSS
- Dr.Waleed Samir portfolio CI